HIV and COVID-19 – What We’ve Learned

Paul Sax, MD, FIDSA, sits down with Patrick Passarelli, MD, a med-peds ID physician at Dartmouth-Hitchcock and ID editor for theMednet, to explore how clinicians can get expert guidance beyond AI. They dive into the origins of theMednet, what makes a great clinical question, and ...  Show more

In a special encore presentation in honor of Black History Month, Let’s Talk ID host and IDSA Board member Mati Hlatshwayo Davis, MD, MPH, FIDSA, speaks with HIVMA Chair Allison Agwu, MD, ScM, FIDSA, HIVMA Immediate Past Chair Michelle Cespedes, MD, MS, and Darrell McBride, DO, a ...  Show more

When HIV was first identified in the early 1980s, it was a public health crisis mired in urgent scientific questions: How was it transmitted? What were the symptoms? Could it be treated? But alongside that, and equally challenging to public health, was the stigma attached to t ...

Dr Lucy Dorrell tells us how our immune system controls HIV and how we can live with this virus. There are currently around 91,000 people in the UK living with HIV/AIDS. HIV is a challenging target for a vaccine because it can mutate its genetic makeup. Dr Lucy Dorrell aims to de ...  Show more

Humanes Immundefizienzvirus: Zwischen verpassten Diagnosen und Lichtblicken in der Forschung. 

Drs Michael S. Saag and Monica Gandhi discuss COVID-19 and the impact this pandemic has had on patients diagnosed with HIV, including vaccines, boosters, and patients who are older or have chronic comorbid conditions. Relevant disclosures can be found with the episode show notes ...  Show more